Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats

World Journal of Gastroenterology

Volumn 9, Issue 12, 2003, Pages 2676-2680

  Qian, Jun ^a   Vossoughi, Daryusch ^b   Woitaschek, Dirk ^b   Oppermann, Elsie ^b   Bechstein, Wolf O ^b   Li, Wei Yong ^a   Feng, Gan Sheng ^a   Vogl, Thomas ^b  

^a UNION HOSPITAL   (China)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLETILLA STRIATA; CHINESE DRUG; IODINATED POPPYSEED OIL; MITOMYCIN; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CATHETERIZATION; CHEMOEMBOLIZATION; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HEPATIC ARTERY LIGATION; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIDACEAE; PATHOLOGY; PHYTOTHERAPY; PROSPECTIVE STUDY; RANDOMIZATION; RAT; RAT STRAIN; SOLID TUMOR; TUMOR GROWTH; TUMOR VOLUME;

EID: 0348228051     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i12.2676     Document Type: Article

References (45)

1. Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35(5 Suppl 2): S130-S137
2. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-335
3. Tang ZY. Treatment of hepatocellular carcinoma. Digestion 1998; 59: 556-562
4. Franco D, Usatoff V. Resection of hepatocellular carcinoma. Hepatogastroenterology 2001; 48: 33-36
5. Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 47-52
6. Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002; 16: 1-15
7. Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 47-52
8. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486
9. Sturm JW, Keese MA, Bonninghoff RG, Wustner M, Post S. Locally ablative therapies of hepatocellular carcinoma. Onkologie 2001; 24(Suppl 5): 35-45
10. Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 2002; 8: 74-78
11. Li L, Wu PH, Li JQ, Zhang WZ, Lin HG, Zhang YQ. Segmental transcatheter arterial embolization for primary hepatocellular carcinoma. World J Gastroenterol 1998; 4: 511-512
12. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 2002; 37: 350-355
13. Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, Obi S, Sato S, Hamamura K, Omata M. Hepatocellular carcinoma in elderly patients: Beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002; 95: 816-823
14. Jiang HC, Liu LX, Piao DX, Xu J, Zheng M, Zhu AL, Qi SY, Zhang WH, Wu LF. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002; 8: 624-630
15. Allgaier HP, Galandi D, Zuber I, Blum HE. Radiofrequency thermal ablation of hepatocellular carcinoma. Dig Dis 2001; 19: 301-310
16. Vogl TJ, Mack MG, Roggan A, Straub R, Eichler KC, Muller PK, Knappe V, Felix R. Internally cooled power laser for MR-guided interstitial laser-induced thermotherapy of liver lesions: Initial clinical results. Radiology 1998; 209: 381-385
17. Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669-678
18. Itamoto T, Katayama K, Fukuda S, Fukuda T, Yano M, Nakahara H, Okamoto Y, Sugino K, Marubayashi S, Asahara T. Percutaneous microwave coagulation therapy for primary or recurrent hepatocellular carcinoma: Long-term results. Hepatogastroenterology 2001; 48: 1401-1405
19. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, Ikeda K, Inoue K. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-1251
20. Liad inverted question Marko L, Virgili J, Figueras J, Valls C, Dominguez J, Rafecas A, Torras J, Fabregat J, Guardiola J, Jaurrieta E. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000; 88: 50-57
21. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734-1739
22. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000; 214: 349-357
23. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, Carrai M, Maltinti G, Capria A, Conte PF. Treatment of large HCC: Transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197: 812-818
24. Zheng C, Feng G, Liang H. Bletilla striata as a vascular embolizing agent in interventional treatment of primary hepatic carcinoma. Chin Med J 1998; 111: 1060-1063
25. Zheng C, Feng G, Zhou R. New use of Bletilla striata as embolizing agent in the intervention treatment of hepatic carcinoma. Zhonghua Zhongliu Zazhi 1996; 18: 305-307
26. Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, Franklin TD Jr, Grosfeld JL. A reproducible rat liver cancer model for experimental therapy: Introducing a technique of intrahepatic tumor implantation. J Surg Res 1992; 52: 193-198
27. Qian J, Truebenbach J, Graepler F, Pereira P, Huppert P, Eul T, Wiemann G, Claussen C. Application of poly-lactide-coglycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol 2003; 9: 94-98
28. Trubenbach J, Pereira PL, Graepler F, Huppert PE, Eul T, Konig CW, Duda SH, Claussen CD. Animal experiment studies on the effectiveness of permanent occlusion of the hepatic artery in transarterial chemoembolization. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000; 172: 274-277
29. Trubenbach J, Graepler F, Pereira PL, Ruck P, Lauer U, Gregor NM, Claussen CD, Huppert PE. Growth characteristics and imaging properties of the morris hepatoma 3924A in ACI rats: A suitable model for transarterial chemoembolization. Cardiovasc Intervent Radiol 2000; 23: 211-217
30. Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas-an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20-23
31. Achenbach T, Seifert JK, Pitton MB, Schunk K, Junginger T. Chemoembolization for primary liver cancer. Eur J Surg Oncol 2002; 28: 37-41
32. Yan FH, Zhou KR, Cheng JM, Wang JH, Yan ZP, Da RR, Fan J, Ji Y. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol 2002; 8: 658-662
33. Fan J, Ten GJ, He SC, Guo JH, Yang DP, Weng GY. Arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 1998; 4: 33-37
34. Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, Lee HS, Kim CY, Han MC. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992; 182: 709-713
35. Clavien PA, Kang KJ, Selzner N, Morse MA, Suhocki PV. Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis. J Gastrointest Surg 2002; 6: 95-101
36. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79: 2087-2094
37. Lopez RR Jr, Pan SH, Hoffman AL, Ramirez C, Rojter SE, Ramos H, McMonigle M, Lois J. Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002; 137: 653-657
38. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S319-S328
39. Raoul JL. Is chemoembolisation of value in inoperable primary hepatocellular carcinoma. HPB Surg 1998; 10: 406-408
40. Qian J, Feng GS, Vogl TJ. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003; 9:
41. Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Res 1984; 44: 2115-2121
42. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Caxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology 2002; 224: 47-54
43. Feng XS, Qiu FZ, Xu Z. Experimental studies of embolization of different hepatotropic blood vessels using Bletilla striata in dogs. J Tongji Med Univ 1995; 15: 454-459
44. Qian J, Feng G, Liang H. Action of DDPH in the interventional treatment of portal hypertension induced by liver cirrhosis in rabbits. J Tongji Med Univ 1998; 18: 108-112
45. Feng G, Kramann B, Zheng C, Zhou R. Comparative study on the long-term effect of permanent embolization of hepatic artery with Bletilla striata in patients with primary liver cancer. J Tongji Med Univ 1996; 16: 111-116.